Categories
Most Viewed Transcripts
- Netflix Inc (NFLX) Q3 2023 Earnings Call Transcript
- Tesla Inc (TSLA) Q3 2023 Earnings Call Transcript
- Accenture plc (ACN) Q3 2023 Earnings Call Transcript
- Steelcase Inc. (SCS) Q1 2024 Earnings Call Transcript
- Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript
- Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript
Latest News
Analysis
Domino’s Pizza to report Q1 earnings next week. Here’s what to expect
Fast food giant Domino's Pizza, Inc. (NYSE: DPZ) is preparing to release operating results for the first three months of fiscal 2024.
Main takeaways from Hasbro’s (HAS) Q1 2024 earnings report
Shares of Hasbro, Inc. (NASDAQ: HAS) soared 11% on Wednesday after the company delivered better-than-expected earnings results for the first quarter of
Key takeaways from PepsiCo’s Q1 2024 earnings report
Shares of PepsiCo, Inc. (NASDAQ: PEP) were down over 2% on Tuesday, despite the company delivering better-than-expected results for the first quarter
Interviews
AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.
Most Read
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
April 24, 2024
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
April 24, 2024
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
April 24, 2024
Technology
Energy
Consumer
Industrials
Health Care
Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,